HarmoniaMentis Sverige
Additional ONTOZRY® Information
Cenobamate: Redefining Epilepsy Care
Explore guides and expert insights to integrate cenobamate into your practice. Cenobamate: A Shift to Earlier Therapy
Explore new data supporting cenobamate as an early add-on therapy. Cenobamate: Data-Driven Seizure Control
Explore key clinical and real-world data showcasing cenobamate’s efficacy, tolerability, and long-term benefits. Cenobamate: Seizure Freedom in Focus
Explore key findings from the C017 trial, highlighting cenobamate’s dose-dependent seizure reductions. Cenobamate: Expert Titration
Discover key recommendations and insights to manage titration and co-medications effectively in your practice. Cenobamate: Sustained Efficacy and Safety
Explore cenobamate’s retention rates and tolerability, seizure control, and patient adherence. Data of Ontozry use in real-world setting: early vs. late use
Second interim analysis of the BLESS study: efficacy and safety of add-on cenobamate in people with focal onset seizures
Explore guides and expert insights to integrate cenobamate into your practice. Cenobamate: A Shift to Earlier Therapy
Explore new data supporting cenobamate as an early add-on therapy. Cenobamate: Data-Driven Seizure Control
Explore key clinical and real-world data showcasing cenobamate’s efficacy, tolerability, and long-term benefits. Cenobamate: Seizure Freedom in Focus
Explore key findings from the C017 trial, highlighting cenobamate’s dose-dependent seizure reductions. Cenobamate: Expert Titration
Discover key recommendations and insights to manage titration and co-medications effectively in your practice. Cenobamate: Sustained Efficacy and Safety
Explore cenobamate’s retention rates and tolerability, seizure control, and patient adherence. Data of Ontozry use in real-world setting: early vs. late use
Second interim analysis of the BLESS study: efficacy and safety of add-on cenobamate in people with focal onset seizures
MAT-SE-0042-P 6.10.2025
Explore more
Don't miss out!
Would you like to receive news, congress reports, and invitations to lectures on epilepsy and epilepsy treatments?